BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17626182)

  • 1. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
    Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12111-6. PubMed ID: 17626182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
    Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
    Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.
    Quinn BA; Brake T; Hua X; Baxter-Jones K; Litwin S; Ellenson LH; Connolly DC
    PLoS One; 2009 Dec; 4(12):e8404. PubMed ID: 20046879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
    Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
    Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins.
    Szabova L; Gordon MB; Lu L; Pate N; Bassel L; Iacovelli AJ; Karim B; Homan PJ; Householder DB; Guerin TM; Burkett S; Day AM; Custer W; Weaver Ohler Z
    Breast Cancer Res; 2022 Nov; 24(1):75. PubMed ID: 36333737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes.
    Massink MP; Kooi IE; van Mil SE; Jordanova ES; Ameziane N; Dorsman JC; van Beek DM; van der Voorn JP; Sie D; Ylstra B; van Deurzen CH; Martens JW; Smid M; Sieuwerts AM; de Weerd V; Foekens JA; van den Ouweland AM; van Dyk E; Nederlof PM; Waisfisz Q; Meijers-Heijboer H
    Mol Oncol; 2015 Apr; 9(4):877-88. PubMed ID: 25616998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution.
    Kumar P; Mukherjee M; Johnson JP; Patel M; Huey B; Albertson DG; Simin K
    PLoS Genet; 2012; 8(11):e1003027. PubMed ID: 23173005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice.
    Cressman VL; Backlund DC; Avrutskaya AV; Leadon SA; Godfrey V; Koller BH
    Mol Cell Biol; 1999 Oct; 19(10):7061-75. PubMed ID: 10490643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
    Herschkowitz JI; Zhao W; Zhang M; Usary J; Murrow G; Edwards D; Knezevic J; Greene SB; Darr D; Troester MA; Hilsenbeck SG; Medina D; Perou CM; Rosen JM
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2778-83. PubMed ID: 21633010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.
    Scott A; Bai F; Chan HL; Liu S; Ma J; Slingerland JM; Robbins DJ; Capobianco AJ; Pei XH
    Oncotarget; 2016 Dec; 7(51):84496-84507. PubMed ID: 27811360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
    Saal LH; Gruvberger-Saal SK; Persson C; Lövgren K; Jumppanen M; Staaf J; Jönsson G; Pires MM; Maurer M; Holm K; Koujak S; Subramaniyam S; Vallon-Christersson J; Olsson H; Su T; Memeo L; Ludwig T; Ethier SP; Krogh M; Szabolcs M; Murty VV; Isola J; Hibshoosh H; Parsons R; Borg A
    Nat Genet; 2008 Jan; 40(1):102-7. PubMed ID: 18066063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer.
    Zeng J; Singh S; Zhou X; Jiang Y; Casarez E; Atkins KA; Janes KA; Zong H
    Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 37815460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis.
    Nee K; Ma D; Nguyen QH; Pein M; Pervolarakis N; Insua-Rodríguez J; Gong Y; Hernandez G; Alshetaiwi H; Williams J; Rauf M; Dave KR; Boyapati K; Hasnain A; Calderon C; Markaryan A; Edwards R; Lin E; Parajuli R; Zhou P; Nie Q; Shalabi S; LaBarge MA; Kessenbrock K
    Nat Genet; 2023 Apr; 55(4):595-606. PubMed ID: 36914836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of
    Miklikova S; Trnkova L; Plava J; Bohac M; Kuniakova M; Cihova M
    Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33540843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations.
    Menghi F; Barthel FP; Yadav V; Tang M; Ji B; Tang Z; Carter GW; Ruan Y; Scully R; Verhaak RGW; Jonkers J; Liu ET
    Cancer Cell; 2018 Aug; 34(2):197-210.e5. PubMed ID: 30017478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer.
    Zeng J; Singh S; Jiang Y; Casarez E; Atkins KA; Janes KA; Zong H
    bioRxiv; 2023 Apr; ():. PubMed ID: 37163037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer.
    Bennett CN; Green JE
    Toxicol Pathol; 2010 Jan; 38(1):88-95. PubMed ID: 20080934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies.
    Obermiller PS; Tait DL; Holt JT
    Breast Cancer Res; 2000; 2(1):28-31. PubMed ID: 11250690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional in vivo deletion of LYN kinase has little effect on a BRCA1 loss-of-function-associated mammary tumour model.
    Tornillo G; Warrington L; Kendrick H; Higgins AT; Hay T; Beck S; Smalley MJ
    Dis Model Mech; 2024 Jan; 17(1):. PubMed ID: 38149669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.
    Molyneux G; Geyer FC; Magnay FA; McCarthy A; Kendrick H; Natrajan R; Mackay A; Grigoriadis A; Tutt A; Ashworth A; Reis-Filho JS; Smalley MJ
    Cell Stem Cell; 2010 Sep; 7(3):403-17. PubMed ID: 20804975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.